Delivery Order SPE2DB20D2002-SPE2DB26FL00A
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,378.20 for Terbinafine HCL 250 mg tablets (30 count) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.04 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count) with a contract value of $2,205.41. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) with a ceiling value of $1,808.77. This competitively awarded, firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,430.69 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on December 9, 2025, with completion scheduled for December 10, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on December 16, 2025, with a ceiling value of $1,749.89 and ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract action sourced from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through...
- The Defense Logistics Agency awarded a $1,702.44 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count packaging) on December 15, 2025, with completion targeted for December 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania location. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for Terbinafine HCL 250 mg tablets (30-count package) valued at $1,057.00. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,116.74 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count packaging) on December 17, 2025, with an ultimate completion date of December 18, 2025. The contract utilizes firm fixed-price pricing and was awarded competitively without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Terbinafine HCL 250 mg tablets (30-count units) with a ceiling value of $1,477.11. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB26FL00ADelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,838.56 for Terbinafine HCL 250 mg tablets (90-count units) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a prime supplier to the Defense Logistics Agency's Medical Supply Chain, supporting military and veteran healthcare systems with a comprehensive range of pharmaceutical products. As a prime contractor under the DLA's pharmaceutical procurement framework, AmerisourceBergen maintains the capability to fulfill diverse medical supply requirements across multiple therapeutic domains. This particular delivery order for an antifungal medication reflects the company's role in supporting routine pharmaceutical inventory needs for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/28/25 |